A 42-year-old man receives 500 mg of lidocaine for peripheral nerve block during orthopedic surgery. Within 2 minutes, he develops confusion, slurred speech, and muscle twitching. The anesthesiologist suspects local anesthetic systemic toxicity. Which investigation would be most specific for confirming the CNS phase of LAST?

## Investigating the CNS Phase of LAST ### Pathophysiology of CNS Toxicity in LAST **Key Point:** The CNS phase of Local Anesthetic Systemic Toxicity (LAST) results from: 1. **Blockade of inhibitory neuronal pathways (GABA-mediated)** → disinhibition, excitation, and seizure activity 2. **Sodium channel blockade in CNS neurons** → altered membrane excitability 3. **Progressive CNS depression** → coma and apnea at higher plasma concentrations These changes produce a characteristic sequence: **excitatory phase** (confusion, slurred speech, tremors, seizures) followed by **depressive phase** (coma, respiratory arrest). ### Why EEG with Spectral Analysis? **High-Yield:** EEG with spectral analysis is the **most specific investigation** for confirming the CNS phase of LAST because: 1. **Directly measures brain electrical activity** — EEG captures the pathognomonic neurophysiological changes of LAST: initial high-frequency, high-amplitude activity (disinhibition), followed by epileptiform discharges and seizure patterns. 2. **Specificity for CNS-phase confirmation** — while lactate/ABG reflect metabolic consequences (seen in any shock state), EEG changes are directly tied to the neuronal mechanism of local anesthetic toxicity. 3. **Spectral analysis** allows quantitative assessment of seizure burden and CNS depression severity, distinguishing LAST-induced seizures from other causes. 4. **Correlates with plasma lidocaine levels** — EEG slowing and seizure activity correlate with CNS lidocaine concentrations in pharmacokinetic studies (Tucker GT, Br J Anaesth 1986). **Clinical Pearl:** In the research and monitoring context, **EEG spectral analysis** is used to define the CNS phase of LAST precisely — it is the gold-standard neurophysiological tool for confirming seizure activity and CNS excitation/depression phases. ### Why Not the Other Options? | Investigation | Why Not Most Specific for CNS-Phase LAST | |---|---| | **Plasma cholinesterase** | Relevant to ester local anesthetic metabolism (procaine, cocaine); lidocaine is an **amide** — not metabolized by cholinesterase. Not specific for LAST at all. | | **Serum lactate / Base deficit (ABG)** | Reflects metabolic acidosis and mitochondrial dysfunction — **sensitive** for LAST severity but **not specific** for the CNS phase. Elevated in any shock, sepsis, or hypoperfusion state. | | **Transcranial Doppler** | Assesses cerebral blood flow velocity; not a diagnostic or confirmatory test for LAST CNS toxicity. | **Key Distinction:** The stem asks for the investigation **most specific for confirming the CNS phase** — EEG directly measures the neuronal excitability changes that define this phase. Lactate/ABG are useful for severity assessment but are non-specific (elevated in any metabolic crisis). ### Clinical Integration **Key Point:** In clinical practice, LAST is diagnosed clinically (acute CNS/cardiac symptoms after local anesthetic injection). However, when asked which investigation is **most specific** for the CNS phase, EEG with spectral analysis is the correct answer — it directly captures the pathophysiological hallmark (seizure activity, CNS excitation/depression) rather than a downstream metabolic consequence. [cite: Tucker GT. Pharmacokinetics of local anaesthetics. Br J Anaesth. 1986;58(7):717-731; Neal JM et al. ASRA Practice Advisory on Local Anesthetic Systemic Toxicity. Reg Anesth Pain Med. 2018;43(2):113-123]